2011 – 2020 of 2680
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Beta-blocker treatment before angiotensin-converting enzyme inhibitor therapy in newly diagnosed heart failure
(
- Contribution to journal › Letter
-
Mark
APC-PCI complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden.
(
- Contribution to journal › Letter
-
Mark
Introduction: evolutionary processes in sexual conflicts
(
- Contribution to journal › Letter
-
Mark
Should para-phenylenediamine (PPD) 1% pet. be part of commercially available standard series?
(
- Contribution to journal › Letter
-
Mark
Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence?
(
- Contribution to journal › Letter
-
Mark
Changing analytical approaches in European epidemiology - a short comment on a recent article.
(
- Contribution to journal › Letter
-
Mark
Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling.
(
- Contribution to journal › Letter
-
Mark
Microbes as trigger for primary biliary cirrhosis and primary sclerosing cholangitis.
(
- Contribution to journal › Letter
-
Mark
Looking for a better widget: Response to Cuijpers and Van Straten
(
- Contribution to journal › Letter
-
Mark
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination - a rebuttal
(
- Contribution to journal › Letter